Jeffrey S. Farrow - 27 Sep 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Sep 2022
Net transactions value
+$387,909
Form type
4
Filing time
29 Sep 2022, 20:48:26 UTC
Previous filing
06 Sep 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise $387,909 +23,653 +766% $16.40* 26,739 27 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Stock Option (Right to Buy) Options Exercise $0 -23,653 -70% $0.000000 10,299 27 Sep 2022 Common Stock 23,653 $16.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock underlying the option vested in equal quarterly installments over 16 quarters from January 17, 2017 through January 17, 2021.